Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × Watchful Waiting × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 4 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Biopsy 5 Specimen Handling 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 belinostat 2 X-Rays 2 Whole-Body Irradiation 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 ruxolitinib 1 romidepsin 1 fludarabine 1 enasidenib 1 duvelisib 1 cemiplimab 1 brincidofovir 1 Triamcinolone 1 Tacrolimus 1 Spinal Puncture 1 Solutions 1 Rituximab 1 Photons 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡